BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Press Releases

  ImmunoPrecise Advances Universal Dengue Vaccine, Confirming Safety, Immune Activation, and Structural Stability Using its LENSai™ Platform Powered by Patented HYFT® Technology

  June 24, 2025

   · 

  8 min read
• Press Releases

  DATROWAY® approved in the US for patients with previously treated advanced EGFR-mutated non-small cell lung cancer

  June 24, 2025

   · 

  19 min read
• Press Releases

  Injectable Drugs Market to Reach USD 1,032.78 Billion by 2032, Expanding at a CAGR of 7.7% | Coherent Market Insights

  June 24, 2025

   · 

  1 min read
• Press Releases

  United Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered Liver

  June 24, 2025

   · 

  8 min read
• Press Releases

  Abeona Therapeutics® Announces Publication in The Lancet of Phase 3 VIITAL™ Study Data in Recessive Dystrophic Epidermolysis Bullosa

  June 24, 2025

   · 

  9 min read
• Press Releases

  Plus Therapeutics Announces Comprehensive Restructuring of $15 Million March 2025 Equity Financing

  June 24, 2025

   · 

  6 min read
• Press Releases

  Regeneron Announces First-of-its-Kind Donation Matching Program with Independent Charitable Patient Assistance Organization

  June 24, 2025

   · 

  8 min read
• Press Releases

  Lexeo Therapeutics, Perceptive Xontogeny Venture Funds and venBio Partners Announce Partnership to Advance Novel Cardiac RNA Therapeutics

  June 24, 2025

   · 

  5 min read
• Press Releases

  Neuron23 Announces $96.5 Million Series D Financing and First Patient Dosed in Global Phase 2 NEULARK Clinical Trial of NEU-411 for Early Parkinson’s Disease

  June 24, 2025

   · 

  5 min read
• Press Releases

  Starton Therapeutics and Bend Bioscience Enter into Development Agreement for Oral Controlled Release Dosage Form of STAR-LLD (lenalidomide)

  June 24, 2025

   · 

  4 min read